These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12502504)

  • 1. Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats.
    Kuhlmann J; Neumann-Haefelin C; Belz U; Kalisch J; Juretschke HP; Stein M; Kleinschmidt E; Kramer W; Herling AW
    Diabetes; 2003 Jan; 52(1):138-44. PubMed ID: 12502504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of intramyocellular lipid following short-term rosiglitazone treatment in Zucker fatty rats: an in vivo nuclear magnetic resonance study.
    Jucker BM; Schaeffer TR; Haimbach RE; Mayer ME; Ohlstein DH; Smith SA; Cobitz AR; Sarkar SK
    Metabolism; 2003 Feb; 52(2):218-25. PubMed ID: 12601636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute exercise on lipid content and dietary lipid uptake in liver and skeletal muscle of lean and diabetic rats.
    Janssens S; Jonkers RA; Groen AK; Nicolay K; van Loon LJ; Prompers JJ
    Am J Physiol Endocrinol Metab; 2015 Nov; 309(10):E874-83. PubMed ID: 26419590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy study of soleus muscle in non-obese healthy and Type 2 diabetic Asian Northern Indian males: high intramyocellular lipid content correlates with excess body fat and abdominal obesity.
    Misra A; Sinha S; Kumar M; Jagannathan NR; Pandey RM
    Diabet Med; 2003 May; 20(5):361-7. PubMed ID: 12752484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of skeletal muscle glycogen synthesis and glycolysis in rosiglitazone-treated Zucker fatty rats: an in vivo nuclear magnetic resonance study.
    Jucker BM; Schaeffer TR; Haimbach RE; McIntosh TS; Chun D; Mayer M; Ohlstein DH; Davis HM; Smith SA; Cobitz AR; Sarkar SK
    Diabetes; 2002 Jul; 51(7):2066-73. PubMed ID: 12086934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity.
    Sinha R; Dufour S; Petersen KF; LeBon V; Enoksson S; Ma YZ; Savoye M; Rothman DL; Shulman GI; Caprio S
    Diabetes; 2002 Apr; 51(4):1022-7. PubMed ID: 11916921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
    Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
    Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance.
    Korach-André M; Gao J; Gounarides JS; Deacon R; Islam A; Laurent D
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E106-16. PubMed ID: 15328072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.
    Jacob S; Machann J; Rett K; Brechtel K; Volk A; Renn W; Maerker E; Matthaei S; Schick F; Claussen CD; Häring HU
    Diabetes; 1999 May; 48(5):1113-9. PubMed ID: 10331418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone treatment restores in vivo muscle oxidative capacity in a rat model of diabetes.
    Wessels B; Ciapaite J; van den Broek NM; Houten SM; Nicolay K; Prompers JJ
    Diabetes Obes Metab; 2015 Jan; 17(1):52-60. PubMed ID: 25200673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age and muscle-type modulated role of intramyocellular lipids in the progression of insulin resistance in nondiabetic Zucker rats.
    Korach-André M; Gounarides J; Deacon R; Beil M; Sun D; Gao J; Laurent D
    Metabolism; 2005 Apr; 54(4):522-8. PubMed ID: 15798961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects.
    Schrauwen-Hinderling VB; Kooi ME; Hesselink MK; Jeneson JA; Backes WH; van Echteld CJ; van Engelshoven JM; Mensink M; Schrauwen P
    Diabetologia; 2007 Jan; 50(1):113-20. PubMed ID: 17093944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of intramyocellular lipid concentrations in rat hindleg muscle.
    Neumann-Haefelin C; Kuhlmann J; Belz U; Kalisch J; Quint M; Gerl M; Juretschke HP; Herling AW
    Magn Reson Med; 2003 Aug; 50(2):242-8. PubMed ID: 12876699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats.
    Maier VH; Melvin DR; Lister CA; Chapman H; Gould GW; Murphy GJ
    Diabetes; 2000 Apr; 49(4):618-25. PubMed ID: 10871200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipocyte differentiation-related protein and OXPAT in rat and human skeletal muscle: involvement in lipid accumulation and type 2 diabetes mellitus.
    Minnaard R; Schrauwen P; Schaart G; Jorgensen JA; Lenaers E; Mensink M; Hesselink MK
    J Clin Endocrinol Metab; 2009 Oct; 94(10):4077-85. PubMed ID: 19602560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats.
    Beha A; Juretschke HP; Kuhlmann J; Neumann-Haefelin C; Belz U; Gerl M; Kramer W; Roden M; Herling AW
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E989-97. PubMed ID: 16380389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents.
    Singh Ahuja H; Liu S; Crombie DL; Boehm M; Leibowitz MD; Heyman RA; Depre C; Nagy L; Tontonoz P; Davies PJ
    Mol Pharmacol; 2001 Apr; 59(4):765-73. PubMed ID: 11259621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats.
    Dobbins RL; Szczepaniak LS; Bentley B; Esser V; Myhill J; McGarry JD
    Diabetes; 2001 Jan; 50(1):123-30. PubMed ID: 11147777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats.
    Hockings PD; Changani KK; Saeed N; Reid DG; Birmingham J; O'Brien P; Osborne J; Toseland CN; Buckingham RE
    Diabetes Obes Metab; 2003 Jul; 5(4):234-43. PubMed ID: 12795656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats.
    Cipriani S; Mencarelli A; Palladino G; Fiorucci S
    J Lipid Res; 2010 Apr; 51(4):771-84. PubMed ID: 19783811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.